Vancomycin 1,000 MG intravenous injectio
Ended Awarded
- Contract number
- SPE2D322F391G
- Awardee
-
Xellia Pharmaceuticals USA LLC UEI VPASKCGXVUD1
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,205
Award facts
- Contract value 100% obligated
- $11,205.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Buffalo Grove, IL 60089, USA
Award details come from SAM.gov/FPDS.
About this award
Xellia Pharmaceuticals USA LLC was awarded an $11,205 firm fixed price delivery order against an unspecified government-wide acquisition contract vehicle to supply 4558037014 Vancomycin 1,000 mg intravenous injections to the Defense Logistics Agency Troop Support Medical. Performance will take place in Buffalo Grove, Illinois with an expected completion date of August 12, 2022. No set-aside designation was applied to this order for pharmaceutical products in support of the Defense Logistics Agency's medical supply chain responsibilities.
Quick answers
Who was awarded contract SPE2D322F391G?
SPE2D322F391G was awarded to Xellia Pharmaceuticals USA LLC by Medical Supply Chain (Troop Support) on August 9, 2022.
How much is contract SPE2D322F391G worth?
The government has obligated $11,205 on SPE2D322F391G.
Is contract SPE2D322F391G an order under another contract?
Yes. SPE2D322F391G is a delivery order under SPE2D020D0002, an indefinite delivery contract.
Was contract SPE2D322F391G competed?
The extent of competition for SPE2D322F391G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award